bioAffinity Technologies (BIAF) EBT Margin (2022 - 2026)
bioAffinity Technologies (BIAF) reported EBT Margin of 268.63% for Q1 2026, down 12557.0% year-over-year from N/an in Q1 2025, and down 36.52% quarter-over-quarter from 196.78% in Q4 2025.
bioAffinity Technologies (BIAF) EBT Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of EBT Margin data on file, last reported at 268.63% in Q1 2026.
- EBT Margin for Q1 2026 came in at 268.63%, down 12557.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 279.95% (down 16959.0% YoY), and the FY2025 annual result was 241.25%, down 14482.0% from the prior year.
- EBT Margin eased to 268.63% in Q1 2026 per BIAF's latest filing, from 196.78% in the prior quarter.
- Over five years, EBT Margin peaked at 81.37% in Q1 2024 and troughed at 427752.87% in Q3 2022.
- A 5-year average of 42646.84% and a median of 293.11% in 2025 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 42698613 bps in 2023 and fell as far as 205101 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 71380.39% in 2022, then surged by 100 bps to 107.12% in 2023, then slipped by 25 bps to 134.4% in 2024, then sank by 46 bps to 196.78% in 2025, then tumbled by 37 bps to 268.63% in 2026.
- Business Quant data shows BIAF's EBT Margin at 268.63% in Q1 2026, 196.78% in Q4 2025, and 349.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 22.23% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.17% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 7.90% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 22.14% |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | -268.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268.63% |
| Dec 31, 2025 | -196.78% |
| Sep 30, 2025 | -349.08% |
| Jun 30, 2025 | -317.59% |
| Mar 31, 2025 | -143.06% |
| Dec 31, 2024 | -134.40% |
| Sep 30, 2024 | -85.02% |
| Jun 30, 2024 | -87.79% |
| Mar 31, 2024 | -81.37% |
| Dec 31, 2023 | -107.12% |
| Sep 30, 2023 | -766.74% |
| Jun 30, 2023 | -8,793.12% |
| Mar 31, 2023 | -165,143.43% |
| Dec 31, 2022 | -71,380.39% |
| Sep 30, 2022 | -427,752.87% |
| Jun 30, 2022 | -6,742.11% |